Effect of Febuxostat Compared to Placebo on Exercise Tolerance in Participants With Chronic Stable Angina
Status:
Terminated
Trial end date:
2012-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effect of febuxostat, once daily (QD), compared
to placebo as an add on to stable anti-anginal therapy, on the total exercise time of
participants with Chronic Stable Angina.